Ticker LaunchFiled, not priced · BRBM
BirchBioMed Inc.
BirchBioMed Inc. publicly filed a registration statement on Form S-1 on Aug 12, 2026 for a proposed initial public offering on Nasdaq Global Market under the ticker BRBM, and has not yet priced. Its latest amendment was filed on Oct 9, 2026.
BirchBioMed Inc. is a clinical-stage biopharmaceutical company, founded in 2015, developing treatments for scarring and related skin disorders, autoimmune diseases and organ fibrosis. It holds exclusive licenses from UBC for its FS1/FS2 and AI-001 technologies, including FS2 for topical scar prevention.
- Status
- Filed, not priced
- Ticker
- BRBM
- Exchange
- Nasdaq Global Market
- First filed
- Aug 12, 2026
- Latest amendment
- Oct 9, 2026
- Sector
- Biotech & pharma
- Country / state
- Ontario, Canada
More on this listing for subscribers
- Amendment history
Every record in the database also has its full filing timeline, a daily-updated calendar, watchlist alerts and Excel export.
Then $99/month or $999/year. Cancel anytime.
Filings
- Registration statement (S-1) first filed Aug 12, 2026
- Latest amendment Oct 9, 2026
- All filings on EDGAR CIK 1670747
Other companies in the IPO pipeline
- CoVolt Power, Inc.Aug 21, 2026
- Hualink Tech IncAug 18, 2026
- Ray Maple Inc.Aug 18, 2026
- Bang MAI Fang HoldingsAug 17, 2026
- Aura Consolidated Group, Inc.Aug 11, 2026
- Zensitive Holding LtdAug 7, 2026